Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Andreas P. Wagner Sells 19,399 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Andreas P. Wagner sold 19,399 shares of the stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $15.26, for a total value of $296,028.74. Following the transaction, the insider now directly owns 204,075 shares in the company, valued at approximately $3,114,184.50. The trade was a 8.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Alignment Healthcare Stock Down 0.9%

Shares of NASDAQ ALHC traded down $0.14 during midday trading on Friday, hitting $14.94. 1,581,551 shares of the company's stock were exchanged, compared to its average volume of 2,044,923. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. Alignment Healthcare, Inc. has a twelve month low of $7.05 and a twelve month high of $21.06. The company has a market cap of $2.96 billion, a PE ratio of -19.40 and a beta of 1.22. The firm's fifty day simple moving average is $16.37 and its 200-day simple moving average is $14.90.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business had revenue of $926.93 million for the quarter, compared to analyst estimates of $889.83 million. During the same quarter last year, the company earned ($0.25) EPS. The business's quarterly revenue was up 47.5% on a year-over-year basis. Research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ALHC has been the topic of several research reports. Bank of America increased their target price on Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Robert W. Baird increased their target price on Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 15th. Piper Sandler increased their price target on Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a research report on Tuesday, March 4th. Finally, JPMorgan Chase & Co. increased their price target on Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a research report on Thursday, March 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $17.17.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. MCF Advisors LLC grew its stake in Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after buying an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new position in Alignment Healthcare during the 1st quarter worth approximately $42,000. Amalgamated Bank grew its stake in Alignment Healthcare by 21.6% during the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after buying an additional 616 shares during the last quarter. RiverPark Advisors LLC purchased a new position in Alignment Healthcare during the 4th quarter worth approximately $106,000. Finally, Regal Partners Ltd purchased a new position in Alignment Healthcare during the 1st quarter worth approximately $194,000. Hedge funds and other institutional investors own 86.19% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.